Exhaled breath acetone for predicting cardiac and overall mortality in chronic heart failure patient...
Exhaled breath acetone for predicting cardiac and overall mortality in chronic heart failure patients
About this item
Full title
Author / Creator
Marcondes‐Braga, Fabiana G. , Gioli‐Pereira, Luciana , Bernardez‐Pereira, Sabrina , Batista, Guilherme L. , Mangini, Sandrigo , Issa, Victor S. , Fernandes, Fabio , Bocchi, Edimar A. , Ayub‐Ferreira, Silvia M. , Mansur, Alfredo J. , Gutz, Ivano G.R. , Krieger, Jose E. , Pereira, Alexandre C. and Bacal, Fernando
Publisher
England: John Wiley & Sons, Inc
Journal title
Language
English
Formats
Publication information
Publisher
England: John Wiley & Sons, Inc
Subjects
More information
Scope and Contents
Contents
Aims
Exhaled breath acetone (EBA) has been described as a new biomarker of heart failure (HF) diagnosis. EBA concentration increases according to severity of HF and is associated with poor prognosis, especially in acute decompensated HF. However, there are no data on chronic HF patients. The aim is to evaluate the role of EBA for predicting card...
Alternative Titles
Full title
Exhaled breath acetone for predicting cardiac and overall mortality in chronic heart failure patients
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_7236fbc86c514f3b9ce620da04cee729
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_7236fbc86c514f3b9ce620da04cee729
Other Identifiers
ISSN
2055-5822
E-ISSN
2055-5822
DOI
10.1002/ehf2.12736
